ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO487

The Impact of Uraemia on Oxidative Stress Signalling Pathways in the Presence of NPHP Mutations

Session Information

Category: Genetic Diseases of the Kidneys

  • 1001 Genetic Diseases of the Kidneys: Cystic

Author

  • Gupta, Shabarni, Macquarie University, Sydney, New South Wales, Australia

Group or Team Name

  • Phillips and Atkin Laboratory, Faculty of Medicine and Health Sciences, Macquarie University
Background

Mutations in the Nek8 gene, encoding a member of the serine/threonine protein kinase family related to NIMA (never in mitosis, gene A), are associated with nephronophthisis (NPHP9); a juvenile form of autosomal recessive cystic kidney disease. With the onset of cystic disease due to the genetic mutation, deteriorating renal health leads to accumulation and circulation of several toxins acting as a double-edged sword. This study investigates any synergistic effect between mutation in the Nek8 gene and the uraemic toxin, indoxyl sulphate (IS) in driving an unfolded protein response (UPR) as an indicator of cellular stress.

Methods

Hek293 cells transiently expressing wild-type (WT) or H425Y mutant Nek8 found in human NPHP patients were used. UPR was investigated by monitoring expression of BiP and XBP1s using protein and RNA, respectively, from cells expressing WT and H425Y Nek8 alone, and in the presence of 5mM IS for 8hr (n = 3). Tunicamycin treated Hek293 cells were used as positive control (2.5µg/ml, 4hr). Data was analyzed using 2-way ANOVA.

Results

Overexpression of H425Y Nek8 did not result in elevating UPR markers (BiP and XBP1s) in comparison to WT. However, presence of IS, resulted in upregulation of BiP in WT by 1.45-fold and H425Y by 1.54-fold (calculated as mean ± SEM, p <0.05, n=3) in comparison to untreated WT. XBP1s was upregulated by 2-fold in treated WT and 3.1-fold in treated H425Y cells (calculated as mean ± SEM, p < 0.05, n=3), in comparison to WT untreated cells, such that this increased expression was significantly greater in H425Y Nek8 mutant cells.

Conclusion

Results from this study indicate that overexpression of the human variant of the Nek8 mutation, as a standalone, is unable to trigger the UPR pathway. However, in presence of uraemic toxin IS, expressions of both BiP and XBP1s in WT and H425Y cells are elevated. The greater elevation of XBP1s expression in treated H425Y compared to treated WT cells is consistent with the hypothesis that UPR responses triggered by uraemic toxins are potentiated in presence of the Nek8 mutation. Further studies examining additional markers of UPR and measures of cellular stress will further elucidate the impact of uraemic toxins and their interaction with PKD mutations and their potential impact on kidney function.

Funding

  • Private Foundation Support